New AI Tool Uses Routine Blood Tests to Predict Immunotherapy Response for Many Cancers
The artificial intelligence–based model, dubbed SCORPIO, was developed by a team of researchers from Memorial Sloan Kettering Cancer Center (MSK) and the Tisch Cancer Institute at Mount Sinai.